A major clinical trial has found that by interrupting the treatment of vulnerable people on long-term immune suppressing medicines for two weeks after a COVID-19 booster vaccination, their antibody response to the jab is doubled.
Home Science Interrupting treatment of vulnerable people on immune-suppressing medicines doubles their antibody response...
Interrupting treatment of vulnerable people on immune-suppressing medicines doubles their antibody response to COVID-19 booster vaccination, study finds
